Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I Trial of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Doxorubicin and Cyclophosphamide in Children With Relapsed Solid Tumors: A Children's Oncology Group Study
Authors
Rheingold, Susan R.; Hogarty, Michael D.; Blaney, Susan M.; Zwiebel, James A.; Sauk-Schubert, Calies; Chandula, Reddy; Krailo, Mark D.; Adamson, Peter C.
Publication
Journal of Clinical Oncology, 2007, Vol 25, Issue 12, p1512